Novartis AG
said its head of pharmaceuticals, David Epstein, is to leave the company amid a restructuring that will split his role in two.
The Basel, Switzerland-based drug giant said Mr. Epstein, who is American, had decided to leave the company to explore new challenges from the U.S. Chief Executive Joe Jimenez said Mr. Epstein had steered our pharmaceuticals division through a period of excellence in innovation, execution and improved financial results.
Novartis disclosed Mr. Epsteins departure as the company announced plans to separate its cancer unit from …
Read the full article at: http://www.wsj.com/articles/novartis-to-split-pharmaceuticals-division-into-two-1463506092